论文部分内容阅读
目的:观察艾迪注射液联合顺铂胸腔内注射对晚期日肺癌症治疗效果。方法:选取肺癌并恶性胸腔积液患者35例B超定位胸腔刺(闭式引流)尽量抽净胸腔积液,及顺铂40～60mg,胸腔内注射液50ml,每日1次,视胸腔积液是多少连用2～4次。结果:会诊35例中,完全缓解10例占28.5%。部分缓解18例,占51.5%。多变化7例占20%。总有效率80%,不良反应轻微,患者均可耐受。结论:艾迪注射液联合顺铂胸腔内胸腔内注射治疗恶性胸腔积液一种安全有效的治疗方法,值得临床推广使用。
Objective: To observe the therapeutic effect of Aidi injection combined with cisplatin intrapleural injection on advanced lung cancer. Methods: Thirty-five patients with lung cancer and malignant pleural effusion underwent choledochosurgical thoracentesis (closed drainage) aspiration of pleural effusion, and cisplatin 40 ~ 60mg, intrathoracic injection 50ml, once a day, depending on the pleural effusion How much liquid is used in conjunction 2 to 4 times. Results: Of the 35 cases who were treated, 10 cases (28.5%) were completely relieved. Partial relief in 18 cases, accounting for 51.5%. 7 cases of multiple changes accounted for 20%. The total efficiency of 80%, minor adverse reactions, patients can tolerate. Conclusion: Aidi injection combined with intrapleural thoracic injection of cisplatin in the treatment of malignant pleural effusion is a safe and effective treatment, which is worthy of clinical application.